Vanda Pharmaceuticals Inc (USD)
VNDA
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range11.64 | 12.10
52-Wk Range- | -
Last Close11.85
Mkt Cap (m)646.42
Dividend yield-
ISINUS9216591084
Volume262,907.00
Exchange VenueNAS

Company Profile

Vanda Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders to address unmet needs.

Key Information
Price/Earning5.56
Price/Book1.55
Price/Sales2.76
P/CF18.54
Rev Growth (3 year avg)15.88
EPS Growth (3 year avg)-
Operating Margin % 10.04
Net Margin %50.86
Return on Equity33.67
Debt/Equity0.04

Documents

Prospectus
en 16/03/2018
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

http://www.vandapharma.com

Financials

Income Statement
USD201420152016201720182019
Revenue (m)50.16109.93146.02165.08193.12227.19
Operating Income (m)-57.55-40.19-18.57-16.9021.7422.81
Net Income (m)20.19-39.87-18.01-15.5725.21115.55
Basic EPS0.58-0.94-0.41-0.350.502.17
Avg. Diluted Shares Outstanding (m)36.6942.2543.4544.7453.0554.85
Balance Sheet
USD201420152016201720182019
Current Assets (m)141.73166.55174.18169.86299.13354.14
Non Current Assets (m)29.9746.5036.2035.5733.00129.61
Total Assets (m)171.70213.05210.37205.43332.13483.75
Current Liabilities (m)7.7951.3250.3270.3653.0259.51
Total Liabilities (m)------
Total Equity (m)160.82133.03131.33131.39275.42410.95
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)-81.5512.45-8.10-1.9829.9945.95
Capital Expenditure (m)-8.77-2.53-1.41-1.66-25.37-1.02
Figures are quoted in USD unless stated otherwise
-
No change
$
11.85
Last Price